Lisata Therapeutics, Inc. Banner Image

Lisata Therapeutics, Inc.

  • Ticker LSTA
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Lisata Therapeutics, Inc. Logo Image
  • 11-50 Employees
  • Based in Basking Ridge, New Jersey
Lisata Therapeutics is a clinical-stage pharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Lisata’s lead product candidate, LSTA1, is an investigational drug designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs toMore target and penetrate solid tumors more effectively. Based on Lisata’s CendR Platform® Technology, Lisata has already established noteworthy commercial and R&D partnerships. The company projects the announcement of many clinical study and business milestones over the next 2 years, having indicated that its current business and development plan is funded with available capital through these milestones and into early 2026.
4.8 / 5.0 (214)

Lisata Therapeutics, Inc. reports have an aggregate usefulness score of 4.8 based on 214 reviews.

Lisata Therapeutics, Inc.

Most Recent Annual Report

Lisata Therapeutics, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Lisata Therapeutics, Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Lisata Therapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!